AVI Systems Celebrates 50 Years of Innovation and Excellence in Audiovisual, Unified Collaboration and Digital Media Solutions
MINNEAPOLIS–(BUSINESS WIRE)–AVI Systems, the largest global audiovisual and unified collaboration systems integrator, today acknowledged its 50th year... Read more.
Future Technologies Continues Expansion into U.S. Energy Market With New Office In West Texas
Future Technologies set to open office in Southwest region in an effort to better serve its Oil & Gas, Petrochemical, and Renewables Clients. SUWANEE, Ga.–(BUSINESS... Read more.
Sypris Reports Fourth Quarter Results
Revenue Up 17%; Backlog Exceeds $115 Million LOUISVILLE, Ky.–(BUSINESS WIRE)–$SYPR–Sypris Solutions, Inc. (Nasdaq/GM: SYPR) today reported financial... Read more.
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic…
SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Â Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI... Read more.
2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron
– Company Now Exclusively Focused on Development and Commercialization of Abecma – CAMBRIDGE, Mass.–(BUSINESS WIRE)–#TSVT—2seventy... Read more.
Freedom Holding Corp. CEO, Timur Turlov, to Deliver Keynote Speech at LD Micro Inaugural New York Investor Conference
Freedom Capital Markets NYC Family Office Summit Attendance Also on CEO Schedule ALMATY, Kazakhstan & NEW YORK–(BUSINESS WIRE)–Freedom Holding Corp.... Read more.
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Novum IQ Infusion Platform now offers large volume and syringe infusion smart pumps on an integrated system with shared innovative digital health solutions to help... Read more.
Ellington Residential Announces Strategic Transformation
– Focus on CLO Investments Expected to Enhance Earnings, Reduce Volatility and Drive Book Value Growth, Utilizing Less Leverage – – Company Revokes... Read more.
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$QNCX–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative... Read more.
Guess?, Inc. Announces Issuance of Approximately $12.1 Million of Additional 3.75% Convertible Notes Due 2028 and Retirement of Approximately $14.6 Million of Existing 2.00% Convertible Notes Due 2024
The additional convertible senior notes due 2028 issued in exchange for our existing convertible senior notes due 2024 will augment the exchange and subscription... Read more.